QRG Capital Management Inc. Sells 25,373 Shares of Intuitive Surgical, Inc. $ISRG

QRG Capital Management Inc. lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 53,299 shares of the medical equipment provider’s stock after selling 25,373 shares during the period. QRG Capital Management Inc.’s holdings in Intuitive Surgical were worth $23,837,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of ISRG. Pinnacle Bancorp Inc. grew its holdings in Intuitive Surgical by 4.1% during the 2nd quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock valued at $289,000 after purchasing an additional 21 shares during the last quarter. Vertex Planning Partners LLC grew its position in Intuitive Surgical by 2.3% in the 2nd quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock valued at $498,000 after acquiring an additional 21 shares during the last quarter. City Holding Co. increased its stake in Intuitive Surgical by 16.1% in the second quarter. City Holding Co. now owns 159 shares of the medical equipment provider’s stock worth $86,000 after purchasing an additional 22 shares during the period. True Vision MN LLC lifted its position in shares of Intuitive Surgical by 3.0% during the second quarter. True Vision MN LLC now owns 766 shares of the medical equipment provider’s stock worth $416,000 after purchasing an additional 22 shares during the last quarter. Finally, Evermay Wealth Management LLC boosted its stake in shares of Intuitive Surgical by 3.1% during the second quarter. Evermay Wealth Management LLC now owns 731 shares of the medical equipment provider’s stock valued at $397,000 after purchasing an additional 22 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts recently commented on ISRG shares. Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Citigroup lowered shares of Intuitive Surgical from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $650.00 to $635.00 in a research report on Thursday, December 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Truist Financial raised their price objective on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. Finally, Barclays reiterated an “overweight” rating and issued a $686.00 target price (up from $635.00) on shares of Intuitive Surgical in a report on Wednesday, January 7th. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $622.17.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Phase‑3 update on IS‑001 imaging drug — Intuitive advanced its Phase‑3 study aimed at reducing ureter injuries in robotic colorectal surgery, a safety-focused adjoint that could expand the company’s addressable offering and reinforce surgical‑safety differentiation. Intuitive Surgical Advances Phase 3 Imaging Drug
• Positive Sentiment: daVinci systems demand highlighted — Company commentary and industry coverage say system performance “exceeded expectations” and Intuitive is pushing for more placements, supporting procedure growth and recurring consumable revenue. Intuitive says daVinci systems ‘exceeded expectations,’ it wants more
• Positive Sentiment: Analyst support remains — At least some brokers (e.g., Bernstein) have reiterated buy ratings, signaling continued sell‑side conviction in ISRG’s long‑term growth profile despite near‑term noise. Bernstein Sticks to Their Buy Rating for Intuitive Surgical (ISRG)
• Positive Sentiment: Investor take: “buying the dip” narratives are emerging — Several bullish commentaries argue the pullback is an entry point given Intuitive’s wide moat, recurring consumables and procedure tailwinds. Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder
• Neutral Sentiment: Analysts preparing for Q4 — Preview pieces outline the metrics (procedures, system placements, ASPs, margin drivers) that will matter when full Q4 results and guidance details arrive; these previews can amplify volatility around the print. Intuitive Surgical (ISRG) Q4 Earnings on the Horizon
• Neutral Sentiment: Brokerage commentary roundup — Coverage pieces remind investors that analyst ratings and model changes often move shares; they’re useful context but not a definitive signal by themselves. Brokers Suggest Investing in Intuitive Surgical (ISRG)
• Negative Sentiment: Preliminary Q4 revenue reaction — Although Intuitive reported strong preliminary Q4 and full‑year revenue growth, shares dipped as investors parsed procedure trends, margin dynamics and what management said about demand cadence. That disconnect between a beat and stock action is a key reason for the pullback. Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results
• Negative Sentiment: Softer 2026 outlook flagged — Company commentary and reporting point to a softer 2026 outlook that trimmed forward expectations, which is the primary negative driver behind today’s weakness. Intuitive Surgical Sets Softer 2026 Outlook
• Negative Sentiment: Market reaction analysis — Coverage asking “why did shares dive?” notes investors punished the stock for guidance/trajectory concerns despite the beat, illustrating that forward commentary and margin clarity matter more than one‑time beats. Intuitive Surgical Crushed Fourth-Quarter Forecasts. So Why Did Shares Dive?

Intuitive Surgical Trading Down 1.2%

Shares of ISRG stock opened at $535.00 on Friday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The business’s fifty day simple moving average is $566.32 and its 200-day simple moving average is $512.24. The company has a market cap of $191.79 billion, a PE ratio of 70.77, a PEG ratio of 4.40 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the business earned $1.84 EPS. The firm’s revenue for the quarter was up 22.9% on a year-over-year basis. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other news, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the sale, the executive vice president directly owned 3,056 shares in the company, valued at approximately $1,772,480. The trade was a 81.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Mark Brosius sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $547.36, for a total value of $2,463,120.00. Following the sale, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $496,455.52. This represents a 83.23% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 114,007 shares of company stock valued at $63,533,844. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.